{ "model": { "rank": 5263, "code": "thing-q243257", "model_id": "vr.tr.chikungunya", "name": "chikungunya", "purpose": "Enable an agent to recognise a possible chikungunya episode, assess diagnostic certainty and functional burden, and identify appropriate clinical and transmission-prevention actions.", "family": "Thing Registry", "category": "Cross-cutting context", "status": "research-draft", "kind": "thing", "plane": "XCT", "domain": "XCT.QLT", "industry": "", "version": "", "url": "/models/thing/q243257/", "tier": 2, "score": 68, "payload": { "layer": "wikidata", "aliases": [], "aliasCount": 0, "merged": 0, "knownIn": 68, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q243257", "url": "https://www.wikidata.org/wiki/Q243257", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-09T22:00:30Z", "providers": [ "Codex" ], "breadth": "recalled by Codex without web access - no source was read", "missingProviders": [], "pass": 2, "cost": { "grok": { "seconds": 19.2, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a0882e-b872-7ee1-a598-6af03d21fabd\n--------\nuser\nDescribe what is already known about one registered thing. Answer as JSON only, no prose around it.\n\nThing: chikungunya\nSense to describe: (none recorded)\nDomain code: XCT.STA\nAlso known as: (none)\n\n\nContext for this batch of 1001 things:\n# Batch 005: 1001 reg", "usd": 0, "recall": true }, "codex": { "seconds": 72.4, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a0882e-b869-7143-bb09-76ac2a17a6d4\n--------\nuser\nYou are drafting a Vercy meta-model for one registered thing. Answer as JSON only, no prose around it.\n\nThing: chikungunya\nRegistry id: vr.tr.chikungunya\nPlane / domain: XCT / XCT.STA\nRegistry definition: (none recorded)\nNames folded into this entry: (none)\n\n\n" } } }, "metaModel": { "id": "THING-Q243257", "registryId": "vr.tr.chikungunya", "name": "chikungunya", "version": "0.1.0-research.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "XCT.STA" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q243257/", "model": { "registry_id": "vr.tr.chikungunya", "name": "chikungunya", "purpose": "Enable an agent to recognise a possible chikungunya episode, assess diagnostic certainty and functional burden, and identify appropriate clinical and transmission-prevention actions.", "definition": "Chikungunya is a mosquito-borne infectious disease caused by chikungunya virus, typically producing acute fever and marked joint pain that can persist or recur after the acute illness.", "scope_statement": "This model owns chikungunya as a human disease state under vr.tr.chikungunya, including suspected and confirmed episodes, prolonged joint manifestations, and disease-specific decision constraints; it distinguishes the disease from its causative virus and mosquito vectors.", "in_scope": [ "Recognition and evidence-based classification of a suspected or confirmed chikungunya episode", "Exposure history and plausible acquisition context", "Interpretation of diagnostic evidence relative to symptom onset", "Acute illness, complications, persistent joint symptoms, and functional recovery", "Disease-specific care constraints, prevention opportunities, and public-health handoffs" ], "out_of_scope": [ "Chikungunya virus taxonomy, genome structure, and laboratory propagation", "Aedes mosquito biology and comprehensive vector-control programme design", "Full models of dengue, Zika, malaria, and inflammatory arthritis", "Vaccine manufacturing, product specifications, and regulatory dossiers", "Population-level outbreak simulation and general healthcare service management" ], "distinguishing_features": [ "Require a relationship to chikungunya virus infection: fever and joint pain alone do not identify the disease, and the disease episode is distinct from the virus entity.", "Record abrupt fever with prominent, often bilateral joint pain as a recognition pattern, while retaining dengue and Zika as competing explanations; symptoms alone cannot reliably establish the diagnosis. See [WHO chikungunya fact sheet](https://www.who.int/en/news-room/fact-sheets/detail/chikungunya).", "Distinguish appropriately timed viral RNA detection from antibody evidence: an isolated antibody result must not automatically identify when infection occurred. See [CDC diagnostic guidance](https://www.cdc.gov/chikungunya/hcp/diagnosis-testing/index.html).", "Treat persistent or relapsing joint symptoms after the acute illness as a possible chikungunya-related course, while separately evaluating other rheumatologic explanations. See [CDC clinical guidance](https://www.cdc.gov/chikungunya/hcp/clinical-signs/index.html)." ], "characteristics": [ { "name": "Episode classification", "kind": "state", "unit_or_values": "Suspected, probable, confirmed, excluded, or unresolved, using a named case definition and version", "why_it_matters": "Separates a recognition hypothesis from a classification supported by specified evidence." }, { "name": "Time since symptom onset", "kind": "measurement", "unit_or_values": "Days, with onset date and uncertainty interval", "why_it_matters": "Anchors diagnostic interpretation, disease course, and transmission-prevention timing." }, { "name": "Acquisition context", "kind": "relation", "unit_or_values": "Links to residence, travel, exposure dates, local transmission evidence, and possible transmission route", "why_it_matters": "Supports exposure plausibility without treating geography as diagnostic proof." }, { "name": "Diagnostic evidence", "kind": "relation", "unit_or_values": "Links to specimens, collection dates, assay types, results, laboratories, and confirmatory tests", "why_it_matters": "Makes classification traceable and allows reassessment when additional results arrive." }, { "name": "Joint symptom distribution", "kind": "category", "unit_or_values": "Named joints, laterality, pain, swelling, stiffness, and clinician-observed inflammation", "why_it_matters": "Distinguishes reported arthralgia from documented arthritis and supports longitudinal comparison." }, { "name": "Pain and functional limitation", "kind": "measurement", "unit_or_values": "Named pain scale and score; walking, self-care, sleep, and work limitations with observation dates", "why_it_matters": "Captures disability that fever resolution alone would miss." }, { "name": "Disease course", "kind": "state", "unit_or_values": "Acute illness, persistent symptoms, relapsing symptoms, recovered, or uncertain; phase thresholds explicitly sourced", "why_it_matters": "Prevents inconsistent duration labels from obscuring progression." }, { "name": "Severe disease vulnerability", "kind": "relation", "unit_or_values": "Age, relevant comorbidities, pregnancy timing, and neonatal exposure context", "why_it_matters": "Provides context for clinician assessment and follow-up priority." }, { "name": "Dengue assessment", "kind": "state", "unit_or_values": "Not assessed, under investigation, supported, or excluded under a documented clinical assessment", "why_it_matters": "Preserves a competing diagnosis that can change medication safety decisions." } ], "affordances": [ "Assemble an episode timeline linking exposure, symptom onset, specimen collection, and recovery.", "Identify missing diagnostic evidence and suggest clinician review of whether additional testing is appropriate.", "Flag unresolved dengue assessment before an agent proposes pain-management options.", "Track joint symptoms and everyday function to support follow-up or specialist referral.", "Identify time-sensitive mosquito-bite prevention and jurisdiction-specific reporting handoffs.", "Retrieve current, jurisdiction-specific vaccine guidance for an exposed or travelling person without assuming universal eligibility." ] }, "sources": [], "structure": { "bundles": [ { "id": "disease-identity-and-boundaries", "name": "Disease identity and boundaries", "description": "Establish what qualifies as a chikungunya disease episode and preserve competing explanations.", "rationale": "The registry lacks a definition, and the disease must not be conflated with its pathogen, an exposure, or an undifferentiated febrile illness.", "layers": [ { "id": "episode-definition", "name": "Episode definition", "description": "Represent disease identity and case classification explicitly.", "findings": [ { "id": "case-definition-and-certainty", "name": "Case definition and certainty", "description": "Record the authority and version of the case definition, the evidence satisfying its criteria, and whether the label serves clinical care or surveillance.", "questions": [ { "text": "Which clinical or surveillance definition governs this episode's suspected, probable, or confirmed classification?", "kind": "definition", "id": "case-definition-and-certainty-q01" }, { "text": "Does the record describe symptomatic disease, asymptomatic infection, past infection, or exposure without evidence of infection?", "kind": "boundary", "id": "case-definition-and-certainty-q02" } ] } ] }, { "id": "competing-and-coexisting-diagnoses", "name": "Competing and coexisting diagnoses", "description": "Separate chikungunya from illnesses with overlapping presentations without assuming mutual exclusion.", "findings": [ { "id": "differential-evidence", "name": "Differential evidence", "description": "Retain evidence for dengue, Zika, other exposure-relevant febrile illnesses, and alternative causes of joint symptoms.", "questions": [ { "text": "Which findings and tests support chikungunya over dengue, Zika, or other locally relevant diagnoses?", "kind": "boundary", "id": "differential-evidence-q01" }, { "text": "What evidence supports a concurrent infection or an independent joint disorder rather than a single explanation?", "kind": "provenance", "id": "differential-evidence-q02" } ] } ] } ] }, { "id": "exposure-and-transmission", "name": "Exposure and transmission", "description": "Connect the episode to plausible acquisition and opportunities to prevent onward transmission.", "rationale": "Chikungunya interpretation depends on where and when exposure occurred and on the relationship between an infected person and mosquito vectors.", "layers": [ { "id": "acquisition-history", "name": "Acquisition history", "description": "Reconstruct location and exposure timing without inferring infection solely from travel.", "findings": [ { "id": "plausible-exposure-window", "name": "Plausible exposure window", "description": "Link residence, travel, mosquito exposure, and dated local transmission reports to symptom onset; preserve uncertainty about acquisition location.", "questions": [ { "text": "Which locations and exposure dates plausibly precede onset under the incubation range used by the selected reference?", "kind": "measurement", "id": "plausible-exposure-window-q01" }, { "text": "Which dated source establishes chikungunya transmission at each proposed acquisition location?", "kind": "provenance", "id": "plausible-exposure-window-q02" } ] } ] }, { "id": "onward-transmission-context", "name": "Onward transmission context", "description": "Identify mosquito-mediated prevention needs and special exposure pathways.", "findings": [ { "id": "transmission-prevention-window", "name": "Transmission-prevention window", "description": "Record bite-prevention needs during early illness and any maternal illness near delivery or blood-exposure context requiring specific assessment. CDC advises preventing mosquito exposure during the first week of illness. See [CDC treatment and prevention guidance](https://www.cdc.gov/chikungunya/hcp/treatment-prevention/).", "questions": [ { "text": "Where is the person relative to symptom onset, and what mosquito-bite prevention measures are feasible now?", "kind": "action", "id": "transmission-prevention-window-q01" }, { "text": "Is there a perinatal or blood-exposure circumstance requiring a separate clinical or public-health handoff?", "kind": "boundary", "id": "transmission-prevention-window-q02" } ] } ] } ] }, { "id": "diagnostic-evidence-and-timing", "name": "Diagnostic evidence and timing", "description": "Interpret laboratory evidence in its temporal and methodological context.", "rationale": "A result's meaning changes with collection timing and assay type; an unqualified positive or negative label loses essential information.", "layers": [ { "id": "specimen-and-assay-timeline", "name": "Specimen and assay timeline", "description": "Relate each result to symptom onset and the test's intended detection window.", "findings": [ { "id": "time-qualified-test-result", "name": "Time-qualified test result", "description": "Capture specimen type, collection date, assay, result, and laboratory interpretation. RNA testing is used during acute infection, while serology becomes useful after the first week. See [CDC diagnostic guidance](https://www.cdc.gov/chikungunya/hcp/diagnosis-testing/index.html).", "questions": [ { "text": "How many days after onset was each specimen collected, and was the assay appropriate for that interval?", "kind": "measurement", "id": "time-qualified-test-result-q01" }, { "text": "Does a negative result justify exclusion, or does its timing warrant clinician-directed follow-up testing?", "kind": "action", "id": "time-qualified-test-result-q02" } ] } ] }, { "id": "confirmation-and-discordance", "name": "Confirmation and discordance", "description": "Resolve provisional or conflicting evidence without overstating certainty.", "findings": [ { "id": "antibody-confirmation-and-attribution", "name": "Antibody confirmation and attribution", "description": "Record whether a positive IgM result received confirmatory neutralizing-antibody testing and distinguish evidence of infection from attribution of the current symptoms. See [CDC diagnostic guidance](https://www.cdc.gov/chikungunya/hcp/diagnosis-testing/index.html).", "questions": [ { "text": "What confirmation supports the antibody result, and what limitations did the laboratory report?", "kind": "provenance", "id": "antibody-confirmation-and-attribution-q01" }, { "text": "How do prior illness, vaccination history, and conflicting results affect attribution to the current episode?", "kind": "boundary", "id": "antibody-confirmation-and-attribution-q02" } ] } ] } ] }, { "id": "clinical-course-and-joint-burden", "name": "Clinical course and joint burden", "description": "Track acute severity and the prolonged musculoskeletal consequences that can dominate recovery.", "rationale": "Chikungunya can remain disabling after the initial fever has resolved, so episode state cannot be represented by infection confirmation alone.", "layers": [ { "id": "acute-manifestations-and-severity", "name": "Acute manifestations and severity", "description": "Record the presenting syndrome, clinical deterioration, and vulnerability context.", "findings": [ { "id": "acute-burden-and-escalation", "name": "Acute burden and escalation", "description": "Track fever, joint pain, hydration, functional ability, and suspected organ involvement alongside age and comorbidities; distinguish risk factors from observed complications.", "questions": [ { "text": "What are the current measured symptoms, functional limitations, and clinician-observed signs of complications?", "kind": "measurement", "id": "acute-burden-and-escalation-q01" }, { "text": "Which current findings meet the applicable clinical pathway's criteria for urgent assessment or hospital care?", "kind": "action", "id": "acute-burden-and-escalation-q02" } ] } ] }, { "id": "persistent-musculoskeletal-course", "name": "Persistent musculoskeletal course", "description": "Follow continuing or relapsing joint symptoms and recovery of everyday function.", "findings": [ { "id": "joint-symptom-trajectory", "name": "Joint symptom trajectory", "description": "Distinguish pain, inflammatory joint findings, and disability over time, preserving the evidence for attributing them to chikungunya.", "questions": [ { "text": "Which joints and daily activities remain affected, for how long, and with what change on repeated assessments?", "kind": "measurement", "id": "joint-symptom-trajectory-q01" }, { "text": "What supports post-chikungunya attribution, and what findings require investigation for another rheumatologic condition?", "kind": "boundary", "id": "joint-symptom-trajectory-q02" } ] } ] } ] }, { "id": "care-prevention-and-handoffs", "name": "Care, prevention, and handoffs", "description": "Connect disease evidence to clinician-led care and current prevention or reporting requirements.", "rationale": "Safe actions depend on unresolved differential diagnoses, the patient's course, and changing local guidance.", "layers": [ { "id": "symptom-care-and-follow-up", "name": "Symptom care and follow-up", "description": "Make treatment prerequisites and reassessment needs explicit.", "findings": [ { "id": "care-decision-constraints", "name": "Care decision constraints", "description": "Record the clinician's supportive-care plan and medication constraints. CDC advises managing suspected chikungunya as dengue until dengue is ruled out, with acetaminophen preferred initially for fever and pain. See [CDC treatment guidance](https://www.cdc.gov/chikungunya/hcp/treatment-prevention/).", "questions": [ { "text": "Has dengue been sufficiently assessed before aspirin or an NSAID is considered, and what patient-specific contraindications apply?", "kind": "action", "id": "care-decision-constraints-q01" }, { "text": "What persistent pain, inflammation, or functional limitation warrants reassessment, rehabilitation, or specialist review?", "kind": "action", "id": "care-decision-constraints-q02" } ] } ] }, { "id": "prevention-and-public-health-interface", "name": "Prevention and public-health interface", "description": "Identify current vaccine guidance and reporting duties without embedding universal product or jurisdiction assumptions.", "findings": [ { "id": "dated-prevention-and-reporting-rules", "name": "Dated prevention and reporting rules", "description": "Link vaccination assessment and suspected or confirmed case reporting to the relevant authority, jurisdiction, effective date, and individual circumstances.", "questions": [ { "text": "Which current local vaccine recommendations apply to this person's age, health status, travel, and exposure context?", "kind": "action", "id": "dated-prevention-and-reporting-rules-q01" }, { "text": "Which authority requires notification of this episode, using what case category and deadline?", "kind": "provenance", "id": "dated-prevention-and-reporting-rules-q02" } ] } ] } ] }, { "id": "evidence-and-external-alignment", "name": "Evidence and external alignment", "description": "What the world already says about this thing, gathered so the model can be checked against it.", "rationale": "A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.", "layers": [ { "id": "reported-evidence", "name": "Reported evidence", "description": "Findings from the breadth pass, kept separate from the structural claims.", "findings": [ { "id": "evidence-confidence-notes", "name": "Check these first", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "This describes the human infectious disease, rather than the virus or an abstract state implied by the supplied domain code.", "Time boundaries separating acute, post-acute and chronic disease vary between clinical frameworks.", "This is a recall-based account; current geographic distribution, vaccine recommendations and national reporting requirements require verification." ], "questions": [ { "id": "evidence-confidence-notes-q01", "text": "Which of these check these first hold for the sense of chikungunya this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-kinds", "name": "Kinds and varieties", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Acute chikungunya", "Post-acute chikungunya", "Chronic chikungunya-associated joint disease" ], "questions": [ { "id": "evidence-kinds-q01", "text": "Which of these kinds and varieties hold for the sense of chikungunya this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-identifiers", "name": "Identifiers and schemes", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "scheme": "ICD-10", "value_or_pattern": "A92.0", "note": "WHO classification code for chikungunya virus disease." } ], "questions": [ { "id": "evidence-identifiers-q01", "text": "Which of these identifiers and schemes hold for the sense of chikungunya this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-real-world-use", "name": "Real-world use", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Clinical diagnosis and differential diagnosis of fever with prominent joint pain.", "Public-health surveillance of mosquito-borne disease and outbreaks.", "Laboratory confirmation using viral RNA detection or antibody testing, depending on time since symptom onset.", "Planning mosquito control and prevention of mosquito bites.", "Assessment and follow-up of persistent joint pain and functional impairment." ], "questions": [ { "id": "evidence-real-world-use-q01", "text": "Which of these real-world use hold for the sense of chikungunya this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-measurements", "name": "Typical measurements", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "quantity": "Incubation period after an infective mosquito bite", "typical_range": "Usually 4-8; reported range approximately 2-12", "unit": "days" }, { "quantity": "Duration of persistent joint symptoms", "typical_range": "Months to years in some affected people", "unit": "time" } ], "questions": [ { "id": "evidence-measurements-q01", "text": "Which of these typical measurements hold for the sense of chikungunya this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-failure-modes-and-hazards", "name": "Failure modes and hazards", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Persistent or recurrent joint pain can cause substantial disability.", "Clinical overlap with dengue and Zika can lead to misclassification.", "Rare severe manifestations include neurological, cardiac and ocular complications.", "Newborns exposed around delivery, older adults and people with underlying conditions have increased risk of severe disease.", "Aedes mosquitoes can sustain outbreaks where vector populations and environmental conditions permit transmission." ], "questions": [ { "id": "evidence-failure-modes-and-hazards-q01", "text": "Which of these failure modes and hazards hold for the sense of chikungunya this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-regional-variation", "name": "Regional variation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Transmission has occurred across Africa, Asia, the Americas and islands of the Indian and Pacific oceans.", "Aedes aegypti and Aedes albopictus differ in local abundance and importance as vectors.", "Temperate regions can experience seasonal local transmission when competent mosquitoes are present and the virus is introduced." ], "questions": [ { "id": "evidence-regional-variation-q01", "text": "Which of these regional variation hold for the sense of chikungunya this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-neighbours", "name": "Neighbouring kinds and how to tell them apart", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "name": "Chikungunya virus", "difference": "The virus is the infectious agent; chikungunya is the disease it causes." }, { "name": "Dengue", "difference": "Dengue is caused by dengue viruses; symptoms and mosquito vectors overlap, so laboratory testing may be needed to distinguish infections." }, { "name": "Zika virus disease", "difference": "Zika is caused by Zika virus and has a different complication profile; overlapping symptoms can require laboratory differentiation." }, { "name": "Rheumatoid arthritis", "difference": "Rheumatoid arthritis is an autoimmune inflammatory disease; chronic chikungunya-associated arthritis follows chikungunya infection and can resemble it clinically." } ], "questions": [ { "id": "evidence-neighbours-q01", "text": "Which of these neighbouring kinds and how to tell them apart hold for the sense of chikungunya this model covers, and on what evidence?", "kind": "provenance" } ] } ] } ] } ] }, "openQuestions": [ "Which authoritative case definitions and duration thresholds should govern acute, post-acute, and chronic states across the jurisdictions this model must serve?", "Which validated measures best capture chikungunya-related joint disability across ages, languages, and care settings?", "What evidence is sufficient to attribute persistent inflammatory joint disease to chikungunya rather than a coincident or newly apparent rheumatologic disorder?", "How should prior vaccination and assay-specific limitations alter interpretation of antibody evidence for a new suspected episode?", "Which current clinical pathways should supply escalation criteria and persistent-joint-symptom management rules, and how will their updates be incorporated?" ], "statistics": { "bundles": 6, "layers": 11, "findings": 18, "questions": 28 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "abstract concept", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a chikungunya, record what state it is in, and decide what may be done with it.", "whatItIs": "Enable an agent to recognise a possible chikungunya episode, assess diagnostic certainty and functional burden, and identify appropriate clinical and transmission-prevention actions.", "characteristics": { "substance": "abstract", "origin": "conceptual", "agency": "inert" }, "whatYouCanDoWithIt": [ "observed and measured" ], "distinguishingFeatures": [ "Described in 68 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a chikungunya, and on what evidence are they told apart?" ], "whatItIsMadeOf": "an abstraction with no physical instance", "physicalCharacter": [ "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state" ], "howItIsRecognised": [ "Nothing to see. What is recognised is an instance of it, and which instances count is exactly what is argued about." ], "relatedModels": [], "standing": "Described in 68 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one chikungunya from another, and a chikungunya from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a chikungunya, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a chikungunya, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a chikungunya is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a chikungunya, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a chikungunya, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a chikungunya is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a chikungunya sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a chikungunya, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a chikungunya, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a chikungunya is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a chikungunya from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a chikungunya, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a chikungunya, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a chikungunya is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a chikungunya passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a chikungunya between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a chikungunya, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a chikungunya, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a chikungunya is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a chikungunya, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a chikungunya is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a chikungunya, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a chikungunya, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a chikungunya is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "definitions-in-contest", "name": "Definitions and who holds them", "description": "What chikungunya is taken to mean, and by whom.", "rationale": "When a field disagrees about a concept, the disagreement is the content. A model that picks one definition silently destroys the information.", "layers": [ { "id": "competing-definitions", "name": "Competing definitions", "description": "The main readings and the traditions behind them.", "findings": [ { "id": "definition-map", "name": "Definitions and their holders", "description": "Each definition with the school or body that holds it.", "questions": [ { "id": "definition-map-q01", "text": "Which definitions of chikungunya are in use, and which tradition or body holds each?", "kind": "definition" }, { "id": "definition-map-q02", "text": "What turns on the difference between them in practice?", "kind": "boundary" } ] } ] }, { "id": "operationalisation", "name": "Operationalisation", "description": "How it is measured or applied when it has to be.", "findings": [ { "id": "operational-record", "name": "Measures and proxies", "description": "Instruments and indicators used to stand in for it.", "questions": [ { "id": "operational-record-q01", "text": "How is chikungunya operationalised or measured in practice, and by what instrument?", "kind": "measurement" }, { "id": "operational-record-q02", "text": "What does that operationalisation leave out, and when does that matter?", "kind": "boundary" } ] } ] } ] }, { "id": "instances-and-use", "name": "Instances, use and consequence", "description": "What counts as an instance of chikungunya and what follows from calling something that.", "rationale": "Applying a concept is an act with consequences, so a model must say what the label licenses and what it does not.", "layers": [ { "id": "instances", "name": "What counts as an instance", "description": "Clear cases, borderline cases and non-cases.", "findings": [ { "id": "instance-tests", "name": "Tests for an instance", "description": "What would settle whether something falls under it.", "questions": [ { "id": "instance-tests-q01", "text": "What would settle whether something is an instance of chikungunya?", "kind": "boundary" }, { "id": "instance-tests-q02", "text": "Which borderline cases are argued about, and on what grounds?", "kind": "definition" } ] } ] }, { "id": "consequence", "name": "Consequence of application", "description": "Rights, duties or decisions that follow from the label.", "findings": [ { "id": "consequence-record", "name": "What the label licenses", "description": "What an agent may do once something is classified this way.", "questions": [ { "id": "consequence-record-q01", "text": "What follows practically once something is treated as chikungunya?", "kind": "action" }, { "id": "consequence-record-q02", "text": "What must an agent not infer from the label alone?", "kind": "action" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a chikungunya came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a chikungunya and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a chikungunya, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a chikungunya, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a chikungunya is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a chikungunya is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a chikungunya, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a chikungunya, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a chikungunya is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 5, "layers": 10, "findings": 12, "questions": 32 } } } }